Neoantigen
Targeted Therapies Market is estimated to be worth USD 3 Billion in 2030,
predicts Roots Analysis
Advances
in bioinformatics and genomic data analysis have enabled the identification of
cancer antigens that are generally overlooked during immune surveillance; these
neoantigens have been shown to possess substantial therapeutic potential
For
more information, please visit https://www.rootsanalysis.com/reports/view_document/neoantigen-targeted-therapies-market-2019-2030/257.html
